Kiromic BioPharma, Inc. – NASDAQ:KRBP
Kiromic BioPharma stock price today
Kiromic BioPharma stock price monthly change
Kiromic BioPharma stock price quarterly change
Kiromic BioPharma stock price yearly change
Kiromic BioPharma key metrics
Market Cap | 1.42M |
Enterprise value | 1.79M |
P/E | -0.07 |
EV/Sales | N/A |
EV/EBITDA | -0.04 |
Price/Sales | N/A |
Price/Book | 0.20 |
PEG ratio | N/A |
EPS | -18.92 |
Revenue | N/A |
EBITDA | -15.92M |
Income | -21.79M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKiromic BioPharma stock price history
Kiromic BioPharma stock forecast
Kiromic BioPharma financial statements
| Jun 2023 | 0 | -6.76M | |
|---|---|---|---|
| Sep 2023 | 0 | -4.19M | |
| Dec 2023 | 0 | -4.69M | |
| Mar 2024 | 0 | -6.14M |
| 2023-06-16 | 0.56 | -14.41 |
|---|
| Jun 2023 | 13636800 | 19.93M | 146.16% |
|---|---|---|---|
| Sep 2023 | 14233500 | 18.72M | 131.53% |
| Dec 2023 | 12169000 | 21.28M | 174.95% |
| Mar 2024 | 12628000 | 19.84M | 157.11% |
| Jun 2023 | -6.46M | 0 | 7.11M |
|---|---|---|---|
| Sep 2023 | -5.22M | -97.5K | 7.00M |
| Dec 2023 | -5.40M | -109.1K | 4.34M |
| Mar 2024 | -5.69M | -21K | 6.19M |
Kiromic BioPharma alternative data
| Aug 2023 | 31 |
|---|---|
| Sep 2023 | 31 |
| Oct 2023 | 31 |
| Nov 2023 | 31 |
| Dec 2023 | 31 |
| Jan 2024 | 31 |
| Feb 2024 | 31 |
| Mar 2024 | 35 |
| Apr 2024 | 35 |
| May 2024 | 35 |
| Jun 2024 | 35 |
| Jul 2024 | 35 |
Kiromic BioPharma other data
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 10701 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | HUNGERFORD BRIAN officer: CFO | Common Stock | 1,000 | $2.6 | $2,600 | ||
Purchase | HUNGERFORD BRIAN officer: CFO | Common Stock | 1,000 | $3.18 | $3,180 | ||
Purchase | BERSANI PIETRO director, officer: CEO | Common Stock | 3,000 | $3.28 | $9,840 | ||
Purchase | NAGEL MICHAEL director | Common Stock | 1,000 | $3.33 | $3,330 | ||
Purchase | BERSANI PIETRO director, officer: CEO | Common Stock | 3,000 | $3.23 | $9,690 | ||
Purchase | MISAJON PAMELA director | Common Stock | 1,701 | $2.93 | $4,984 | ||
Purchase | RALSTON SHANNON 10 percent owner | $2,000,000 Senior Secured Convertible Note | 0 | $2.5 | $0 | ||
Option | DAHLBECK SCOTT officer: Chief Medical Officer | Restricted Stock Units | 17,240 | N/A | N/A | ||
Option | DAHLBECK SCOTT officer: Chief Medical Officer | Common Stock | 17,240 | N/A | N/A | ||
Purchase | CHIRIVA INTERNATI MAURIZIO director, officer.. | Common Stock | 2,800 | $3.7 | $10,357 |
-
What's the price of Kiromic BioPharma stock today?
One share of Kiromic BioPharma stock can currently be purchased for approximately $0.08.
-
When is Kiromic BioPharma's next earnings date?
Unfortunately, Kiromic BioPharma's (KRBP) next earnings date is currently unknown.
-
Does Kiromic BioPharma pay dividends?
No, Kiromic BioPharma does not pay dividends.
-
How much money does Kiromic BioPharma make?
Kiromic BioPharma has a market capitalization of 1.42M. Kiromic BioPharma made a loss 21.29M US dollars in net income (profit) last year or -$14.41 on an earnings per share basis.
-
What is Kiromic BioPharma's stock symbol?
Kiromic BioPharma, Inc. is traded on the NASDAQ under the ticker symbol "KRBP".
-
What is Kiromic BioPharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Kiromic BioPharma?
Shares of Kiromic BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Kiromic BioPharma's key executives?
Kiromic BioPharma's management team includes the following people:
- Mr. Gianluca Rotino Chief Strategy & Innovation Officer and Director(age: 53, pay: $4,810,000)
- Dr. Maurizio Chiriva Internati Ph.D. Founder, Chairman, Chief Executive Officer & Pres(age: 57, pay: $437,900)
-
Is Kiromic BioPharma founder-led company?
Yes, Kiromic BioPharma is a company led by its founder Dr. Maurizio Chiriva Internati Ph.D..
-
How many employees does Kiromic BioPharma have?
As Jul 2024, Kiromic BioPharma employs 35 workers.
-
When Kiromic BioPharma went public?
Kiromic BioPharma, Inc. is publicly traded company for more then 4 years since IPO on 16 Oct 2020.
-
What is Kiromic BioPharma's official website?
The official website for Kiromic BioPharma is kiromic.com.
-
Where are Kiromic BioPharma's headquarters?
Kiromic BioPharma is headquartered at 7707 Fannin, Houston, TX.
-
How can i contact Kiromic BioPharma?
Kiromic BioPharma's mailing address is 7707 Fannin, Houston, TX and company can be reached via phone at 832 968 4888.
Kiromic BioPharma company profile:
Kiromic BioPharma, Inc.
kiromic.comNASDAQ
35
Biotechnology
Healthcare
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Houston, TX 77054
CIK: 0001792581
ISIN: US4976342042
CUSIP: 497634105
